Marcello D’Amelio | Neuroinflammation | Excellence in Research

Posted on by Pencis

Marcello D’Amelio | Neuroinflammation | Excellence in Research

Director Unit of Molecular Neurosciences AT University Campus Bio-medico, Italy

Prof. Dr. Marcello D’Amelio is an esteemed professional in the field of medical sciences, hailing from the University Campus Bio-medico in Italy. šŸ‡®šŸ‡¹ With a rich educational background, he embarked on his academic journey at the University of Bari, Italy, earning his Master’s degree in Medical Genetics in 1994.

Driven by a passion for advancing knowledge, Dr. D’Amelio pursued a Ph.D. at the University of Rome, “Tor Vergata,” specializing in Neurosciences, completing his doctoral studies in 2005. šŸ§  His commitment to the medical field led him to further academic achievements, obtaining a Master’s degree in Clinical Research from the University of Rome, “La Sapienza,” in 2009.

Throughout his educational endeavors, Dr. D’Amelio has demonstrated a keen interest and expertise in diverse aspects of medical sciences, ranging from genetics to neuroscience and clinical research. šŸ§¬šŸ”¬ His academic pursuits and contributions underscore his dedication to advancing the understanding and application of medical knowledge.

PROFILEĀ 

scopus

EDUCATION

Prof. Dr. Marcello D’Amelio, an accomplished professional in the realm of medical sciences, commenced his academic journey at the University of Bari, Italy, earning a Master’s degree in Medical Genetics in 1994. šŸŽ“ Subsequently, he delved into the intricacies of Neurosciences at the University of Rome, “Tor Vergata,” where he attained his Ph.D. in 2005, showcasing a commitment to advancing our understanding of the brain and nervous system. šŸ§ 

Driven by a thirst for knowledge, Dr. D’Amelio furthered his academic pursuits, obtaining a Master’s degree in Clinical Research from the University of Rome, “La Sapienza,” in 2009. šŸ„ This diverse educational background underscores his expertise in bridging genetics, neuroscience, and clinical research, contributing significantly to the medical field. šŸŒ His dedication to multifaceted medical studies positions him as a versatile and accomplished professional in the ever-evolving landscape of healthcare and research.

Experience

From 2015 to 2018, Dr. Marcello D’Amelio served as an Associate Professor in Human Physiology at the Department of Medicine and Surgery, University Campus Bio-medico in Rome, Italy. šŸ›ļø Prior to this, he held the position of Assistant Professor from 2010 to 2014, contributing significantly to the academic landscape. šŸŽ“ His journey into academia began with a Post-doctoral role at the Dulbecco Telethon Institute, Tor Vergata University, Rome, supported by a prestigious Telethon Fellowship from 2008 to 2010. šŸŒ

Dr. D’Amelio’s global research exposure includes visiting scientist roles at renowned institutions such as Vanderbilt University Medical Center and the University of Washington School of Medicine in the United States. šŸŒ The recipient of multiple fellowships, including a PhD fellowship at the Laboratory of Molecular Psychiatry, he has consistently demonstrated excellence in the field of human physiology and molecular research. šŸ§¬āœØ

Awards

Dr. Marcello D’Amelio’s outstanding contributions to neuroscience have been recognized with prestigious accolades. In 2010, he was honored with the Neuroscience Research Prize by the Telethon Foundation, acknowledging his impactful work. šŸ† His dedication to translational research in neurodegeneration garnered the 2013 Bioeconomy Rome International Prize, celebrating young Italian scientists. šŸŒ The following year, the Raffaele Giuliano Prize acknowledged him for the quality and originality of his scientific production. šŸŽ‰ In 2017, the Italian Minister of Health, Beatrice Lorenzin, bestowed upon him a distinguished award for his remarkable scientific merits, further solidifying his position as a leader in the field. šŸ‡®šŸ‡¹šŸ§ 

Publications Top Notes

  1. Early derailment of firing properties in CA1 pyramidal cells in an Alzheimer’s disease mouse model
    • Published in: Experimental Neurology, 2022
    • Authors: Spoleti E., Krashia P., La Barbera L., Nobili A., Lupascu C. A., Giacalone E., Keller F., Migliore M., Renzi M., D’Amelio M.
    • DOI: 10.1016/j.expneurol.2021.113969
    • šŸ§ šŸ­šŸ“š
  2. Nilotinib restores memory function in an Alzheimer’s disease mouse model
    • Published in: Progress in Neurobiology, 2021
    • Authors: La Barbera L, Vedele F, Nobili A, Krashia P, Spoleti E, Latagliata EC, Cutuli D, Cauzzi E, Marino R, Viscomi MT, Petrosini L, Puglisi-Allegra S, Melone M, Keller F, Mercuri NB, Conti F, D’Amelio M
    • šŸ­šŸ§ šŸ“–
  3. Targeting autophagy as a therapeutic strategy in early Alzheimer’s disease
  4. Ventral Tegmental Area in Prodromal Alzheimer’s Disease: Bridging the Gap between Mice and Humans
    • Published in: Journal of Alzheimer’s Disease, 2018
    • Authors: D’Amelio M, Serra L, Bozzali M.
    • DOI: 10.3233/JAD-180094
    • šŸŒšŸ­šŸ§ 
  5. In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer’s disease
    • Published in: Neurobiology of Aging, 2018
    • Authors: Serra L, D’Amelio M*, Di Domenico C, Dipasquale O, Marra C, Mercuri NB, Caltagirone C, Cercignani M, Bozzali M. (*Co-first)
    • DOI: 10.1016/j.neurobiolaging.2018.08.012
    • šŸŒšŸ§ šŸ”„